Search

everythinglearnresearchcommunity

for

Search:↓

The immune processes causing VKH and vitiligo are similar in dogs and humans.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Mutations in the FOXN1 gene cause severe immune issues but don't affect hair and nails.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Adding L-glutamine to the diet of Hanwoo steers may boost their immune system and help them cope with heat.

CD25+ CD4+ Tregs and certain plasma proteins are linked to hair loss.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

Genes related to keratin, skin cell differentiation, and immune functions are key in hedgehog skin and spine development.

Belatacept may be a promising treatment for alopecia areata.

Both HLA-B and MICA are independently linked to alopecia areata.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

C4BPA protein may link acne severity and insulin resistance.

Hair proteins in preschool children and their mothers could indicate developmental changes and health status.

Moderate immune responses help hair growth, while excessive responses slow it down.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.